Denmark - Pharmaceutical products

Description

Procurement No: 1ATC Code: L01BA01Generic name: MethotrexatePharmaceutical form: Concentrate, sterileStrength: 100 mg/mlPackage: 10 mlUnit value: 50 mgVolume in units: (Norway: 26440) (Denmark: 32700) (Iceland:4212)ATC Code: L01BA01Generic name: MethotrexatePharmaceutical form: Concentrate, sterileStrength: 100 mg/mlPackage: 50 mlUnit value: 50 mgVolume in units: (Norway: 113300) (Denmark: 114500) (Iceland: 7410).Under the title “quantity in units”, an estimated consumption of the pharmaceuticals is indicated for each of the countries.It should be noted that this estimate is based on historic consumption data and that the suppliers must expect that the actual purchase under a Framework Agreement may differ significantly from the estimate. Reference is made to Paragraph 3.6 of the tender specifications and Clause 2 of the Framework Agreement.The supplier must have authorisation to produce, import or receive pharmaceuticals for wholesale distribution within the EU/EEA.Marketing authorisations applicable for Denmark, Norway and Iceland must be in place for the pharmaceuticals in sufficient time to ensure that the pharmaceuticals appear in Medicinpriser.dk (Denmark), “Farmalogg” (Norway) and “Lyfjaverðskrá” (Iceland) no later than 1.12.2019. The requirement regarding “Lyfjaverðskrá” (Iceland) only apply if Iceland is part of the Framework Agreement, see Section II.2.11).

Opportunity closing date

21 May 2019

Value of contract

£1m-5m